SCHEMBL8079874

SCHEMBL8079874

CCC[C@H](C(=O)C(=O)O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
KCNQ2 O43526 1/20 0.46
LMNA P02545 2/20 0.45
HSD17B10 Q99714 1/20 0.45
AOC3 Q16853 2/20 0.43
EPHX1 P07099 1/20 0.42
POLB P06746 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9240062 1.00 CYP2C19 (0.48) CYP2C19CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL10442966 0.89 POLB (0.50) LMNAHSD17B10POLBALDH1A1
SCHEMBL9577344 0.87 ASAH1 (0.46) LMNAHSD17B10POLBALDH1A1CES2
SCHEMBL10443250 0.86 ASAH1 (0.48) POLBALDH1A1CES2CES1
SCHEMBL9577433 0.86 ASAH1 (0.48) POLBALDH1A1CES2CES1
SCHEMBL28718558 0.85 CYP2C19 (0.46) CYP2C19CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL19228532 0.84 CYP2C19 (0.53) CYP2C19CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL710418 0.84 LMNA (0.56) KCNQ2LMNAHSD17B10POLBALDH1A1
SCHEMBL643461 0.84 CYP2C19 (0.53) CYP2C19CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL9577449 0.84 FFAR2 (0.49) CYP2C19CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6013662-A ANTITUMOR, ANTICARCINOGENIC AGENTS RHONE-POULENC RORER S.A. (FR) 2000-01-11 US disclosed